… of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial …
用户lD2HN5W0jm0A
3个月前
108
10
已完结
1. 系统已在2025-06-20 14:15:33对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
KA Papp, RG Langley, M Lebwohl, GG Krueger…
The Lancet, 2008
thelancet.com
… against interleukins 12 and 23, has shown therapeutic potential for psoriasis. This study assessed the efficacy and safety of ustekinumab in psoriasis patients and assessed dosing …
